Evaluation of the usefulness of a novel injectable cephalosporin, E1040, and ceftazidime for management of complicated urinary tract infections caused by Pseudomonas aeruginosa and Proteus mirabilis by using the rat urolithiasis model.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples